240 related articles for article (PubMed ID: 12037388)
1. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
[TBL] [Abstract][Full Text] [Related]
2. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
Henning S; Cascorbi I; Münchow B; Jahnke V; Roots I
Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
[TBL] [Abstract][Full Text] [Related]
3. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
4. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
[TBL] [Abstract][Full Text] [Related]
6. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
[TBL] [Abstract][Full Text] [Related]
7. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma.
Katoh T; Boissy R; Nagata N; Kitagawa K; Kuroda Y; Itoh H; Kawamoto T; Bell DA
Int J Cancer; 2000 Jan; 85(1):46-9. PubMed ID: 10585581
[TBL] [Abstract][Full Text] [Related]
8. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population.
Deguchi M; Yoshida S; Kennedy S; Ohara N; Motoyama S; Maruo T
J Soc Gynecol Investig; 2005 Apr; 12(3):208-13. PubMed ID: 15784508
[TBL] [Abstract][Full Text] [Related]
10. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
[TBL] [Abstract][Full Text] [Related]
11. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
Prawan A; Kukongviriyapan V; Tassaneeyakul W; Pairojkul C; Bhudhisawasdi V
Eur J Cancer Prev; 2005 Jun; 14(3):245-50. PubMed ID: 15901993
[TBL] [Abstract][Full Text] [Related]
12. Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China?
Zhang XF; Bian JC; Zhang XY; Zhang ZM; Jiang F; Wang QM; Wang QJ; Cao YY; Tang BM
World J Gastroenterol; 2005 Mar; 11(10):1457-62. PubMed ID: 15770721
[TBL] [Abstract][Full Text] [Related]
13. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
[TBL] [Abstract][Full Text] [Related]
14. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA
Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189
[TBL] [Abstract][Full Text] [Related]
15. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
Blömeke B; Brans R; Coenraads PJ; Dickel H; Bruckner T; Hein DW; Heesen M; Merk HF; Kawakubo Y
Br J Dermatol; 2009 Nov; 161(5):1130-5. PubMed ID: 19663877
[TBL] [Abstract][Full Text] [Related]
16. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
18. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
Smelt VA; Mardon HJ; Sim E
Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
[TBL] [Abstract][Full Text] [Related]
19. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
[TBL] [Abstract][Full Text] [Related]
20. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
